| Announcements
Smilow Ranks High for Patient Satisfaction The patient satisfaction scores for the first quarter of 2011 have been released and the inpatient scores for Smilow Cancer Hospital are the highest at Yale-New Haven Hospital. All four Smilow Oncology Units had the highest satisfaction scores of all areas in YNHH. All units achieved overall satisfaction scores >90%, while NP 12 topped the list this quarter with an overall score of 93.5! Congratulations to Cathy Lyons, Peter Marks, and the entire staff of Smilow Cancer Hospital for their outstanding hard work and continued efforts to provide the best care to our patients.
Gastrointestinal Cancers Symposium Please join members of the Gastrointestinal Cancers Program as they present the latest information on the treatment of patients with colon, pancreatic, and gastric cancers on Wednesday, May 11 at 5 PM in NP 4-101A. This is the third session in Yale Cancer Center's CME Oncology Series. Registration is required and dinner is included. Learn More >>
|
Smilow Cancer Hospital
Thoracic Surgery Goes Robotic Dr. Anthony Kim is performing robotic thoracic lobectomies at Smilow Cancer Hospital. Dr. Kim is currently using this technology to perform lobectomies for the treatment of lung cancer. He is the only surgeon in Connecticut actively performing the procedure and has one of the largest experiences with robotic lung operations in the state. Yale-New Haven Hospital is the leader in Connecticut using robotic technology, having performed over 1,200 robotic procedures since 2008 across multiple specialties including gynecology, urology, thoracic oncology, head and neck cancer, general surgery, and cardiac surgery. Smilow Cancer Hospital has the da Vinci Si, the most advanced robotic platform available. New Smoking Cessation Program Opens at Smilow Smilow Cancer Hospital is now offering a quit smoking program. Developed by Assistant Professor of Psychiatry, Dr. Benjamin Toll, the program aims to help patients quit by combining counseling and drug treatment. The cessation program is offered to all patients being treated at Smilow, for specific cancers. The Smoking Cessation Service at Smilow encourages patients to quit by stressing the benefits quitting will have on their health and their treatment, not by pointing out the harm smoking can cause. The program utilizes the appropriate treatment based on each patient's individual situation and history with smoking.
To find out more information about the service, please contact Dr. Benjamin Toll or Helena Chmielowicz, APRN at (203) 688-1378. |
Notables
William C. Sessa, PhD, a member of the Yale Cancer Center Developmental Therapeutics Program, has been named the Alfred Gilman Professor of Pharmacology. Dr. Sessa is an expert on blood vessel function and also Vice Chair of the department of pharmacology at Yale School of Medicine.
Qin Yan, PhD and Tae Hoon Kim, PhD, members of the Cancer Genetics and Genomics Program, have been selected as the 2011 Stewart Fellowships from Yale Cancer Center.
The award is for $75,000 for each of the next two years.
|
Funding and Award OpportunitiesV Foundation Translational Research Grant The Translational Grant from the V Foundation for Cancer Research provides funding for novel approaches to the prevention, detection, and treatment of human cancer that requires collaboration of investigators from the lab and the clinic. The award totals $600,000 paid in $200,000 installments over a three-year period, beginning in October 2011. Ten percent of the grant annually may be used to offset the indirect costs of the project.
Applications for this award must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise. The research project must bring together pre-clinical and clinical investigators, and may not be currently funded by other mechanisms external to the Yale Cancer Center. The competition is only open to YCC Members, and one application from the Center can be submitted.
If you are interested in applying for the award, please send a one-page project summary (including specific aims) with your CV to Roy Herbst no later than Friday, May 6. Schwartz Center Compassionate Caregiver Award® The call for nominations for the 13th annual Schwartz Center Compassionate Caregiver Award has been extended. This prestigious award honors caregivers in the New England region who display extraordinary compassion in caring for patients. The winner will receive $5,000 and four finalists will receive $1,000 each. Please contact Lisa Barbarotta
if you have any questions. Nomination Deadline:May 18, 2011
Learn More >>
Department of Defense (DOD) Ovarian Cancer Research Program (OCRP) Awards Pilot Award - supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive the field of ovarian cancer research forward. Pre-application Submission Deadline: June 8, 2011 Application Submission Deadline: August 18, 2011 Translational Pilot Award - supports innovative translational research addressing a critical problem or question in ovarian cancer that will accelerate the movement of promising ideas toward clinical applications. Pre-application Submission Deadline: June 8, 2011 Application Submission Deadline: August 18, 2011 Translational Leverage Award - supports the leveraging of existing human-based ovarian cancer resources in translational research to address high-impact research ideas or unmet needs in ovarian cancer. Pre-application Submission Deadline: June 8, 2011 Application Submission Deadline: August 18, 2011 Teal Innovator Award - supports the recruitment of a visionary individual from any field principally outside of, but not exclusive of, ovarian cancer to focus their creativity, innovation, and leadership on ovarian cancer research. Pre-application Submission Deadline: June 8, 2011 Application Submission Deadline: August 18, 2011 Learn More >> Department of Defense (DOD) Breast Cancer Research Program (BCRP) Awards Postdoctoral Fellowship Award - supports the training of exceptionally talented recent doctoral graduates. Individualized training program and mentorship should prepare the PI for an independent career at the forefront of breast cancer research. Proposed research should be innovative and address a critical problem in breast cancer research. Multidisciplinary training encouraged.
Era of Hope Scholar Award - supports exceptionally talented, creative early-career scientists who have demonstrated that they are the "best and brightest" in their fields. Individuals should exhibit strong potential for leadership in the breast cancer community.
Innovator Award - supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field. Provides opportunity to pursue novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer.
Transformative Vision Award - supports a coordinated translational research effort involving multiple PIs to answer a question of major importance in breast cancer prevention or treatment as quickly as possible. Teams must include consumer advocates who will be integrated into the planning and implementation of the research project.
Idea Award (REVISED!) - supports research that has extraordinary potential to yield highly impactful data and lead to critical discoveries or major advancements in breast cancer. Impact is the most important review criterion. Innovation is encouraged, but not required. Preliminary data is allowed, but not required. Collaborative Option supports combining expertise of two PIs to more effectively address a research question.
Learn More >>
|
Cancer Survivors Day
Yale Cancer Center and Smilow Cancer Hospital will celebrate Cancer Survivors Day on Wednesday, May 25 on Yale's West Campus at 5 PM. The celebration will feature keynote speaker Ethan Zohn, winner of Survivor Africa and a cancer survivor.
Following the program, guests will gather for a barbecue picnic. The planning committee would like to have entertainment during dinner. Please contactEmily Fentonif you know of a local band, or have a patient that participates in a musical group that may be willing to perform for a short set that evening.Thank you in advance for your help and suggestions. |
Biostatistical Support - YCAS The Yale Center for Analytical Sciences (YCAS) brings together existing academic strengths in biostatistics, epidemiology, health economics, and health services research at the Yale School of Public Health and collaborative staff to provide expertise for the design, conduct and analysis of health and health care studies, methodological development and education and training to Yale and the extended research community. Yale Cancer Center members have access to the support of YCAS through a collaborative agreement to create a biostatistical shared resource. The Key Functions of the Biostatistics Shared Resource are to: - Assist YCC investigators in the design, conduct and analysis of clinical trials, genomic and proteomic studies as well as population, epidemiologic and prevention studies of cancer.
- Provide review and evaluation of statistical design of studies for the Protocol Review Committee and monitoring of studies for QUACS.
- Provide statistical collaboration for YCC investigators on grant/protocol preparation - statistical design, power and sample size considerations, and analytic and monitoring plans.
- Assist YCC investigators with manuscript preparation and review.
YCAS research design clinics are held every Wednesday from 12 to 2 PM in Room 555 of 300 George Street. Clinics are free of charge. To schedule an appointment, please
contact YCAS
and provide a short description of your research question.
Program Directors:
Peter Peduzzi, PhD
(203) 785-5651
James Dziura, PhD
(203) 737-4468 |
Recent Publications
Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer. Hu Z, Rao B, Chen S, Duanmu J.
Breast Cancer Res Treat. 2011 Apr;126(3):589-600.
Read More >>
Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues. Rimm DL, Nielsen TO, Jewell SD, Rohrer DC, Broadwater G, Waldman F, Mitchell KA, Singh B, Tsongalis GJ, Frankel WL, Magliocco AM, Lara JF, Hsi ED, Bleiweiss IJ, Badve SS, Chen B, Ravdin PM, Schilsky RL, Thor A, Berry DA.
J Clin Oncol. 2011 Apr 25.
Read More >>
Plasma markers for identifying patients with metastatic melanoma.
Kluger HM, Hoyt K, Bacchiocchi A, Mayer T, Kirsch J, Kluger Y, Sznol M, Ariyan S, Molinaro A, Halaban R.
Clin Cancer Res. 2011 Apr 15;17(8):2417-25.
Read More >>
Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables. Bai Y, Tolles J, Cheng H, Siddiqui S, Gopinath A, Pectasides E, Camp RL, Rimm DL, Molinaro AM.
Lab Invest. 2011 Apr 25.
Read More >>
Cell surface signaling molecules in the control of immune responses: a tide model. Zhu Y, Yao S, Chen L.
Immunity. 2011 Apr 22;34(4):466-78.
Read More >>
Invadopodia: RhoC Runs Rings around Cofilin. Macgrath SM, Koleske AJ.
Curr Biol. 2011 Apr 26;21(8):R280-2.
Read More >>
Leukocyte-cancer cell fusion: initiator of the warburg effect in malignancy? Lazova R, Chakraborty A, Pawelek JM.
Adv Exp Med Biol. 2011;714:151-72.
Read More >>
Quality of life among testicular cancer survivors: a case-control study in the United States. Kim C, McGlynn KA, McCorkle R, Erickson RL, Niebuhr DW, Ma S, Graubard B, Aschebrook-Kilfoy B, Barry KH, Zhang Y.
Qual Life Res. 2011 Apr 17.
Read More >>
Peripheral T-cell lymphoma. Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K.
Blood. 2011 Apr 14.
Read More >>
Geographic Analysis of the Radiation Oncology Workforce. Aneja S, Smith BD, Gross CP, Wilson LD, Haffty BG, Roberts K, Yu JB.
Int J Radiat Oncol Biol Phys. 2011 Apr 12.
Read More >>
Testicular Doses in Image-Guided Radiotherapy of Prostate Cancer. Deng J, Chen Z, Yu JB, Roberts KB, Peschel RE, Nath R.
Int J Radiat Oncol Biol Phys. 2011 Apr 12.
Read More >>
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Varughese J, Cocco E, Bellone S, Bellone M, Todeschini P, Carrara L, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
Gynecol Oncol. 2011 Mar 29
Read More >>
|
| |
|
Countdown to the CCSG Submission 392 days until our CCSG grant is due on May 25, 2012.
|
Join Yale Cancer Center on Facebook
|
Inside Yale Cancer Center YaleCares Read the April issue highlighting supplement use. Learn More >> In the News Read recent articles featuring experts from Yale Cancer Center Learn More >>
Subscribe to Yale Cancer Center Answers on iTunes Yale Cancer Center's weekly radio program on CT Public Radio is ranked number 2 in the world for cancer programs on iTunes. Subscribe to the show.
Learn More >>
Cancer Bytes
Hosted by Ellen Matloff, listen to the latest interview with Nathan: Advanced Colon Cancer at age 21 - Not your Average College Experience. Learn More >> Yale Cancer Center Grand Rounds Video presentations from Yale Cancer Center members are now available online.
Learn More >>
DirectConnect Archives Learn More >>
|
Events May 1; 6:00 PM Yale Cancer Center Answers WNPR Gastrointestinal Cancers Stacey Stein, MD Learn More >>
May 3; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street A Holistic Approach to EGFR/HER Receptor Based Diagnostics Nita Maihle, PhD The LPA/Autotaxin Axis - An Emerging Chemotherapeutic Molecular Target Demetrios Braddock, MD, PhD Learn More >>
May 5; 8:00 AM Nutrition and Cancer Survivorship CME Symposium West Campus Nutrition and Cancer Survivorship: Separating the Whole (Wheat) from the Chaff Learn More >>
May 7; 7:00 AM Yale School of Nursing CME Symposium West Campus The Clinical Intersection: A Practical Discussion of Connecticut's Course Mandates Learn More>>
May 8; 6:00 PM Yale Cancer Center Answers WNPR Head and Neck Cancers Benjamin Judson, MD Learn More >> May 10; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street Julia and Patricia Kingsbury Memorial Lecture Issues in the Clinical Management of BRCA-related Breast Cancer Nadine Tung, MD Learn More >>
May 11; 5:00 PM Gastrointestinal Cancers CME Symposium NP 4-101 A and B Presentations from Members of the Yale Cancer Center Gastrointestinal Cancers Program Learn More >> May 12; 4:00 PM Epigenetics Interest Group Meeting BML 137 Qin Yan, PhD Learn More >> |
New Faculty Recruits (May 2009 - Present) Anees Chagpar Surgical Oncology Sandy Chang Lab Medicine Lieping Chen Immunobiology Deborah Chirnomas Pediatric Oncology Leonard Farber Medical Oncology Mark Faries Surgical Oncology Valentina Greco Genetics Stephanie Halene Hematology Roy Herbst Medical Oncology Howard Hochster Medical Oncology Erin Hofstatter Medical Oncology Nina Horowitz Surgical Oncology Michael Hurwitz Medical Oncology Benjamin Judson Otolaryngology Alfred Lee Hematology Arthur Levy Medical Oncology Miguel Materin Ophthalmology Daniel Morgensztern Medical Oncology Don Nguyen Pathology Abhijit Patel Therapeutic Radiology Nikolai Podoltsev Hematology Katie Politi Pathology Tara Sanft Medical Oncology Stacey Stein Medical Oncology Matthew Strout Hematology Narendra Wajapeyee Pathology Qin Yan Pathology |
Submissions Please submit your recent publication and grant announcements to: Renee Gaudette Director, Public Affairs and Marketing
renee.gaudette@yale.edu
|
|
|
